Exeporfinium chloride (XF-73) nasal gel dosed over 24 hours prior to surgery significantly reduced Staphylococcus aureus nasal carriage in cardiac surgery patients: Safety and efficacy results from a randomized placebo-controlled phase 2 study.
Saved in:
| Title: | Exeporfinium chloride (XF-73) nasal gel dosed over 24 hours prior to surgery significantly reduced Staphylococcus aureus nasal carriage in cardiac surgery patients: Safety and efficacy results from a randomized placebo-controlled phase 2 study. |
|---|---|
| Authors: | Mangino JE; Division of Infection Diseases, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, United States., Firstenberg MS; William Novick Global Cardiac Alliance. Aurora, Colorado, United States., Milewski RKC; Department of Surgery, Yale School of Medicine, New Haven, Connecticut, United States., Rhys-Williams W; Destiny Pharma, Brighton, United Kingdom., Lees JP; Destiny Pharma, Brighton, United Kingdom., Dane A; Danestat Consulting Ltd, Macclesfield, United Kingdom., Love WG; Destiny Pharma, Brighton, United Kingdom., Gonzalez Moreno J; Destiny Pharma, Brighton, United Kingdom. |
| Source: | Infection control and hospital epidemiology [Infect Control Hosp Epidemiol] 2023 Jul; Vol. 44 (7), pp. 1171-1173. Date of Electronic Publication: 2023 Mar 23. |
| Publication Type: | Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Cambridge University Press Country of Publication: United States NLM ID: 8804099 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-6834 (Electronic) Linking ISSN: 0899823X NLM ISO Abbreviation: Infect Control Hosp Epidemiol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
